The Claim
In pediatric renal transplant recipients aged 1.3 to 21.7 years who are managed without calcineurin inhibitors, the median terminal half-life of sirolimus is approximately 10.8 hours at one month and 12.1 hours at three months post-transplant, suggesting faster drug clearance compared to adult populations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Kids who got a kidney transplant and are taking a drug called sirolimus clear it from their bodies faster than adults do, especially in the first few months after surgery.
See the scientific wording
In pediatric renal transplant recipients aged 1.3 to 21.7 years managed without calcineurin inhibitors, the median terminal half-life of sirolimus is approximately 10.8 hours at one month and 12.1 hours at three months post-transplant, indicating rapid drug clearance compared to adult populations.
What the research says
1 studyThe study looked at how quickly a drug called sirolimus leaves the body in kids who had kidney transplants and weren’t taking certain other drugs. It found the drug doesn’t last as long in kids as it does in adults, which matches what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.